Home Capital Healthcare

Singapore Paincare grows with acquisitions, broadens services to capture a bigger market

Amala Balakrishner
Amala Balakrishner3/24/2022 08:36 PM GMT+08  • 9 min read
Singapore Paincare grows with acquisitions, broadens services to capture a bigger market
When SPCH debuted on the Catalist Board, its intention was to become a “disruptive force” in the healthcare sector
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

When Singapore Paincare Holdings (SPCH) made its debut on the Catalist Board of the Singapore Exchange (SGX) in July 2020, its intention was to become a “disruptive force” in the healthcare sector.

Two years on, CEO Dr Bernard Lee says the journey thus far has been“exciting.” Apart from raising additional funds, the company has expanded its suite of services and treaments, which has led to improved earnings. For its 1HFY2022 ended Dec 3, 2021, SPCH reported earnings of $2.27 million, up 235.9% y-o-y from the $674,887 posted in the year before. Revenue in the same period was up 70.9% y-o-y to $8.3 million, thanks to the addition of two clinics to its network.

Besides the core business of offering pain management and physiotherapy services, SPCH has also been kept busy with administering the Covid-19 vaccinations under the national vaccination programme. It also benefited from a pick-up in foreign patients when the vaccinated travel lanes (VTL) were announced.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.
Unlock unlimited access to premium articles with less than $9 per month. Subscribe Now